ReCor Medical Inc.

Industry / private company


Location: Palo Alto, CA, United States (USA) (US) US


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Correction to: Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension (PharmacoEconomics - Open, (2024), 10.1007/s41669-024-00472-z) (2024) Taylor RS, Bentley A, Metcalfe K, Lobo MD, Kirtane AJ, Azizi M, Clark C, et al. Journal article, Erratum Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension (2024) Taylor RS, Bentley A, Metcalfe K, Lobo MD, Kirtane AJ, Azizi M, Clark C, et al. Journal article Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial (2023) Azizi M, Saxena M, Wang Y, Jenkins JS, Devireddy C, Rader F, Fisher ND, et al. Journal article Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial (2022) Azizi M, Mahfoud F, Weber MA, Sharp ASP, Schmieder R, Lurz P, Lobo MD, et al. Journal article Changes in blood pressure after crossover to ultrasound renal denervation in patients initially treated with sham in the RADIANCE-HTN SOLO trial (2021) Mahfoud F, Bloch MJ, Azizi M, Wang Y, Schmieder R, Lobo MD, Sharp ASP, et al. Journal article Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial (2021) Azizi M, Sanghvi K, Saxena M, Gosse P, Reilly JP, Levy T, Rump LC, et al. Journal article Predictors of blood pressure response to ultrasound renal denervation in the RADIANCE-HTN SOLO study (2021) Saxena M, Schmieder R, Kirtane AJ, Mahfoud F, Daemen J, Basile J, Lurz P, et al. Journal article 12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation (2020) Azizi M, Daemen J, Lobo MD, Mahfoud F, Sharp AS, Schmieder R, Wang Y, et al. Journal article Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control Following Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial (2019) Azizi M, Schmieder R, Mahfoud F, Weber MA, Daemen J, Lobo MD, Sharp ASP, et al. Journal article Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial (2018) Azizi M, Schmieder R, Mahfoud F, Weber MA, Daemen J, Davies J, Basile J, et al. Journal article